Hypokalemia Among Patients Receiving Treatment for Multidrug-Resistant Tuberculosis

Chest - United States
doi 10.1378/chest.125.3.974
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Low Treatment Initiation Rates Among Multidrug-Resistant Tuberculosis Patients in Gauteng, South Africa, 2011

International Journal of Tuberculosis and Lung Disease
MedicinePulmonaryInfectious DiseasesRespiratory Medicine
2013English

Revolutionary New Treatment Regimens for Multidrug-Resistant Tuberculosis

The Lancet Infectious Diseases
Infectious Diseases
2019English

Final Treatment Outcomes of Multidrug- And Extensively Drug-Resistant Tuberculosis Patients in Latvia Receiving Delamanid-Containing Regimens

European Respiratory Journal
MedicinePulmonaryRespiratory Medicine
2017English

Clofazimine for the Treatment of Multidrug-Resistant Tuberculosis

Clinical Microbiology and Infection
MedicineInfectious DiseasesMicrobiology
2019English

Bedaquiline: New Approach for Treatment of Multidrug-Resistant Tuberculosis

RUHS Journal of Health Science
2019English

Multidrug Resistant Tuberculosis

British Medical Journal
Medicine
2015English

Fluoroquinolone Resistance in Multidrug-Resistant Tuberculosis Patients

Korean Journal of Internal Medicine
Internal Medicine
2019English

Prevalence of Latent Tuberculosis Among Household Contacts of Patients With Multidrug‐resistant Tuberculosis in Vietnam

Respirology
PulmonaryRespiratory Medicine
2019English

Health System Delay in Treatment of Multidrug Resistant Tuberculosis Patients in Bangladesh

BMC Infectious Diseases
Infectious Diseases
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy